Erik Hjorth

Solna, AB 17164, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer's Disease.

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer's Disease.

Journal: Cellular and molecular neurobiology

Published: January 11, 2022

Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in AppNL-G-F/NL-G-F mice.

Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in AppNL-G-F/NL-G-F mice.

Journal: Communications biology

Published: October 14, 2021

Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study.

Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study.

Journal: Journal of Alzheimer's disease : JAD

Published: August 23, 2021

Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer's disease.

Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer's disease.

Journal: Acta neuropathologica communications

Published: May 09, 2021

Cerebrospinal Fluid Inflammatory Markers in Alzheimer's Disease: Influence of Comorbidities.

Cerebrospinal Fluid Inflammatory Markers in Alzheimer's Disease: Influence of Comorbidities.

Journal: Current Alzheimer research

Published: February 10, 2021

Maresin 1 attenuates pro-inflammatory activation induced by β-amyloid and stimulates its uptake.

Maresin 1 attenuates pro-inflammatory activation induced by β-amyloid and stimulates its uptake.

Journal: Journal of cellular and molecular medicine

Published: December 17, 2019

Receptors for pro-resolving mediators are increased in Alzheimer's disease brain.

Receptors for pro-resolving mediators are increased in Alzheimer's disease brain.

Journal: Brain pathology (Zurich, Switzerland)

Published: August 07, 2019

RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome.

RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome.

Journal: Glia

Published: May 05, 2019

Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study.

Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study.

Journal: Journal of Alzheimer's disease : JAD

Published: April 09, 2019

Amyloid-β Peptide Targeting Peptidomimetics for Prevention of Neurotoxicity.

Amyloid-β Peptide Targeting Peptidomimetics for Prevention of Neurotoxicity.

Journal: ACS chemical neuroscience

Published: January 24, 2019

Can inflammation be resolved in Alzheimer's disease?

Can inflammation be resolved in Alzheimer's disease?

Journal: Therapeutic advances in neurological disorders

Published: December 24, 2017

Does Fatty Acid Composition in Subcutaneous Adipose Tissue Differ between Patients with Alzheimer's Disease and Cohabiting Proxies?

Does Fatty Acid Composition in Subcutaneous Adipose Tissue Differ between Patients with Alzheimer's Disease and Cohabiting Proxies?

Journal: Journal of Alzheimer's disease : JAD

Published: November 21, 2017

Showing 1-12 of 28

Last Updated: 09/26/2026